Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Bevacizumab recalled?

Yes — there is an active recall. 1 ongoing FDA recall mention Bevacizumab (27 total). Check the affected lots below.

Most common reason: Sterility / contamination (20 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Bevacizumab. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Bevacizumab recalls on record

none so far in 2026; 27 on record, newest first
Class III · Low risk

Bevacizumab 2.5 mg/0.1 mL

Labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect.

Terminated Labeling / mix-up Pine Pharmaceuticals, LLC NDC 69194-0458-1 D-0531-2023
Class II · Moderate risk

MVASI (bevacizumab-awwb)

Defective container: loose crimp defect, potential loss of container integrity.

Terminated Packaging defect Amgen, Inc. NDC 55513-0206-01 D-0855-2022
Class II · Moderate risk

Mvasi

Lack of Assurance of Sterility

Terminated Sterility / contamination Edge Pharma, LLC NDC 05446-1661-13 D-0412-2022
Class II · Moderate risk

Bevacizumab/Dexamethasone

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Terminated Sterility / contamination Oregon Compounding Centers, Inc. dba Creative Compounds D-0178-2015
Class II · Moderate risk

Bevacizumab

Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.

Terminated Sterility / contamination Specialty Medicine Compounding Pharmacy D-412-2014
Class II · Moderate risk

Bevacizumab 1.25 mg/0.05 mL PF

Lack of Assurance of Sterility: Avella Specialty Pharmacy is recalling bevacizumab and vancomycin due to concerns of sterility assurance with the specialty pharmacy's independent testing laboratory.

Terminated Sterility / contamination Avella of Deer Valley, Inc. D-1058-2013
Class II · Moderate risk

Bevacizumab 25mg/mL

Lack of Assurance of Sterility: Fallon Pharmacy recalled Bevacizumab 25mg/mL due to sterility assurance concerns based on testing of this lot by a third party lab, indicating that test results reported as passing sterility may have been inaccurate.

Terminated Sterility / contamination Fallon Wellness Pharmacy Llc D-66200-001